Technology
Health
Pharmaceutical
Intersect ENT
$33.399876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$33.39
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
+$0.15 (0.45%) Today
$0.00 (0.00%) After Hours
Why Robinhood?
You can buy or sell Intersect ENT and other stocks, options, ETFs, and crypto commission-free!
About
Intersect ENT, Inc. Common Stock, also called Intersect ENT, is a commercial drug delivery company, which engages in the treatment of ear, nose, and throat conditions. Read More The company was founded by Donald J. Eaton in October 2003 and is headquartered in Menlo Park, CA.
Employees
393
Headquarters
Menlo Park, California
Founded
2003
Market Cap
1.02B
Price-Earnings Ratio
—
Dividend Yield
0.00
Average Volume
322.26K
High Today
$34.15
Low Today
$33.01
Open Price
$33.01
Volume
61.14K
52 Week High
$42.95
52 Week Low
$25.09
Collections
Technology
Health
Pharmaceutical
2014 IPO
US
North America
Female CEOs
News
Yahoo FinanceMar 7
Did Intersect ENT’s Share Price Deserve to Gain 89%?
By buying an index fund, investors can approximate the average market return. But if you buy good businesses at attractive prices, your portfolio returns could exceed the average market return. Just take a look at Intersect ENT, Inc. (NASDAQ:XENT), which is up 89%, over three years, soundly beating the market return of 40% (not including dividends). See our latest analysis for Intersect ENT Intersect ENT isn’t currently profitable, so most analysts would look to revenue growth to get an idea of how fast t...
Simply Wall StMar 2
Can You Imagine How Intersect ENT’s Shareholders Feel About The 81% Share Price Increase?
By buying an index fund, you can roughly match the market return with ease. But if you buy good businesses at attractive prices, your portfolio returns could exceed the average market return. Just take a look at Intersect ENT, Inc. (NASDAQ:XENT), which is up 81%, over three years, soundly beating the market return of 40% (not including dividends). View our latest analysis for Intersect ENT Intersect ENT isn’t currently profitable, so most analysts would look to revenue growth to get an idea of how fast th...
Yahoo FinanceMar 1
Edited Transcript of XENT earnings conference call or presentation 25-Feb-19 9:30pm GMT
Q4 2018 Intersect Ent Inc Earnings Call Menlo Park Feb 27, 2019 (Thomson StreetEvents) -- Edited Transcript of Intersect ENT Inc earnings conference call or presentation Monday, February 25, 2019 at 9:30:00pm GMT TEXT version of Transcript Scroll to continue with content Ad ================================================================================ Corporate Participants ================================================================================ * Jeryl L. Hilleman Intersect ENT, Inc. - CF...
Price Paid on Robinhood
16% Higher
Right Now
52 Week Low
$25.09
Average Price Paid
$28.89
52 Week High
$42.95
Earnings
-$0.27
-$0.21
-$0.14
-$0.08
Q2 2017
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Estimated
—
Actual
Expected Apr 30, After Hours